Open AccessQualitative analysis of the capacity to consent to treatment in patients with a chronic neurodegenerative disease: Alzheimer’s disease / Analisi qualitativa sulla capacità a prestare consenso al trattamento in pazienti con malattie cronico degenerative neuropsicoorganiche: Demenza di Alzheimer
Author(s) -
Felice Carabellese,
Alan R. Felthous,
Donatella La Tegola,
Giuseppina Piazzolla,
S. Distaso,
Giancarlo Logroscino,
Antonio Leo,
Antonio Ventriglio,
Roberto Catanesi
Publication year - 2017
Publication title -
international journal of social psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.869
H-Index - 62
eISSN - 1741-2854
pISSN - 0020-7640
DOI - 10.1177/0020764017739642
Subject(s) - disease , medicine , alzheimer's disease , psychology , gerontology , psychiatry , pediatrics
Informed consent is an essential element in doctor-patient relationship. In particular, obtaining valid informed consent from patients with neurocognitive diseases is a critical issue at present. For this reason, we decided to conduct research on elderly patients with Alzheimer's disease ( Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) to assess their capacity to make treatment decisions.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom